Delivery Order W81XWH18D0027-W81XWH18F0099

Award Date 4/9/18
Potential Completion Date 5/1/19
Potential Value $78K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Ann Arbor, MI 48108, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. government. The prime contractor, Amerisourcebergen Drug Corp, is a major pharmaceutical distribution company that provides a wide range of prescription medications, over-the-counter drugs, and medical supplies to various federal agencies, with a focus on serving the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract has a ceiling value of $71,277.30 and...
This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and other government agencies. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a ceiling value of $21,576.34 and is a firm fixed price delivery order contract with a completion date of June 10, 2024. The contract is not set aside for any specific business designation. Amerisourcebergen holds a...
This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and other government agencies. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The award, identified as SPE2DX22D0089|SPE2D824F0R26, is a Delivery Order with a Firm Fixed Price of $20,316.04. It was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the DoD, on June 17, 2022 with a...
This federal contract award was issued by the Defense Health Agency, a defense agency, to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business, for the provision of specialized pharmaceuticals and compounded medications to address drug shortages. The $400,000 firm fixed price contract has an ultimate completion date of September 30, 2016 and does not utilize a set-aside designation. The Compounding Center has received over $700,000 in prior awards from the...
This federal contract award is for the delivery of a variety of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and other government agencies. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that serves as a supplier of prescription medications, over-the-counter drugs, and medical devices to the federal government. The contract, valued at up to $20,455.08, is a Firm Fixed Price Delivery Order issued under...
This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and related agencies. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, which holds an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen...
This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and other government agencies. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, through its Corporate Office Division. The contract has an award ceiling value of $8,392.56 and is a Firm Fixed Price Delivery Order with a completion date of May 28, 2024. It is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award to TDS Med, Inc., a self-certified small disadvantaged business, for the provision of pharmaceutical products to address shortages. The contract was issued by the Defense Health Agency, a defense agency, with a period of performance ending on September 30, 2016 and a ceiling value of $396,538.98. The contract was awarded on a Firm Fixed Price basis under a Blanket Purchase Agreement (BPA) vehicle. No set-aside designation was used. TDS Med, Inc. has previously...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $139,116.17 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract covers the delivery of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits....
This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and other government agencies. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract, valued at up to $58,560.18, is a Firm Fixed Price Delivery Order with an ultimate completion date of June 11, 2024. It is not designated as a set-aside contract....

This is a federal contract award to Aapharmasyn LLC, a small disadvantaged business, for Experimental Therapeutics Medicinal Chemistry services. The contract was awarded by the Defense Health Agency, a component of the U.S. Department of Defense, with a ceiling value of $77,780.00. The contract has a firm fixed price pricing type and was awarded as a delivery order under the Experimental Therapeutics Medicinal Chemistry contract vehicle. The contract does not have a set-aside designation. The award is for the company to provide research and development services in the field of medicinal chemistry to support the Department of Defense, specifically the U.S. Army. The contract has an ultimate completion date of May 1, 2019.

Generated 4/1/25, 9:40 PM